Malin Corporation | MLC - Operating Profit


Malin Corporation reported EUR-1.1M in Operating Profit for its fiscal semester ending in December of 2024.





Operating Profit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.01M 175K Mar/2026
ALKERMES USD -65.93M 17.65M Jun/2026
Avita Medical AUD -10.41M 742K Dec/2025
Dianthus Therapeutics USD -46.53M 23.01M Mar/2026
Eurofins Scientific SE EUR 500M 108.7M Jun/2026
Ionis Pharmaceuticals USD -102.29M 15.71M Jun/2026
IQVIA Holdings USD 2.6B 2.03B Jun/2026
Lonza CHF 673M 243M Jun/2025
Malin Corporation EUR -1.1M 400K Dec/2024
Moderna USD -815M 573M Jun/2026
Organon & Co USD 323M 57M Jun/2026
Ovoca Bio EUR -173K 990K Dec/2025
Revvity USD 126.14M 43.36M Jun/2026
Tectonic Therapeutic USD -27.3M 5.78M Mar/2026
Viatris USD 73.7M 93.9M Jun/2026
Xeris Pharmaceuticals USD 7.92M 8.86M Mar/2026